作者: Alexander Templar , Douglas Marsh , Darren N. Nesbeth
DOI: 10.1186/S40064-016-3074-8
关键词: Genome 、 Molecular biology 、 Synthetic biology 、 Chinese hamster ovary cell 、 Polymerase chain reaction 、 Monoclonal antibody 、 Industry standard 、 Biology
摘要: Background Chinese Hamster Ovary (CHO) cells are the current industry standard for production of therapeutic monoclonal antibodies at commercial scales. Production optimisation in CHO hinges on analytical technologies such as use polymerase chain reaction (PCR) to quantify genetic factors within genome and detect presence contaminant organisms. PCR-based assays, whilst sensitive accurate, limited by (i) requiring lengthy sample preparation (ii) a lack standardisation.